全文获取类型
收费全文 | 3846篇 |
免费 | 237篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 328篇 |
妇产科学 | 78篇 |
基础医学 | 456篇 |
口腔科学 | 45篇 |
临床医学 | 355篇 |
内科学 | 533篇 |
皮肤病学 | 96篇 |
神经病学 | 115篇 |
特种医学 | 147篇 |
外科学 | 475篇 |
综合类 | 389篇 |
预防医学 | 252篇 |
眼科学 | 119篇 |
药学 | 399篇 |
中国医学 | 28篇 |
肿瘤学 | 274篇 |
出版年
2023年 | 37篇 |
2022年 | 53篇 |
2021年 | 87篇 |
2020年 | 76篇 |
2019年 | 70篇 |
2018年 | 85篇 |
2017年 | 69篇 |
2016年 | 62篇 |
2015年 | 108篇 |
2014年 | 117篇 |
2013年 | 147篇 |
2012年 | 260篇 |
2011年 | 226篇 |
2010年 | 163篇 |
2009年 | 137篇 |
2008年 | 149篇 |
2007年 | 162篇 |
2006年 | 195篇 |
2005年 | 149篇 |
2004年 | 170篇 |
2003年 | 111篇 |
2002年 | 126篇 |
2001年 | 77篇 |
2000年 | 88篇 |
1999年 | 98篇 |
1998年 | 83篇 |
1997年 | 74篇 |
1996年 | 81篇 |
1995年 | 39篇 |
1994年 | 49篇 |
1993年 | 31篇 |
1992年 | 62篇 |
1991年 | 48篇 |
1990年 | 41篇 |
1989年 | 37篇 |
1988年 | 54篇 |
1987年 | 38篇 |
1986年 | 50篇 |
1985年 | 42篇 |
1984年 | 36篇 |
1983年 | 30篇 |
1982年 | 18篇 |
1979年 | 15篇 |
1978年 | 18篇 |
1977年 | 16篇 |
1976年 | 18篇 |
1974年 | 14篇 |
1973年 | 15篇 |
1971年 | 17篇 |
1970年 | 20篇 |
排序方式: 共有4105条查询结果,搜索用时 15 毫秒
1.
SK Raina 《Journal of postgraduate medicine》2015,61(3):213-Sep;61(3):213
2.
Katie Mycock Lin Zhan Gavin Taylor-Stokes Gary Milligan Debanjali Mitra 《Current oncology (Toronto, Ont.)》2021,28(1):678
Background: Palbociclib is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor used in combination with aromatase inhibitors or fulvestrant for patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2 (HER2)-negative advanced/metastatic breast cancer (ABC/MBC). Palbociclib was the first CDK 4/6 inhibitor approved for HR+/HER2− ABC/MBC treatment in Canada in combination with letrozole (P+L) as an initial endocrine-based therapy (approved March 2016), or with fulvestrant (P+F) following disease progression after prior endocrine therapy (approved May 2017). The Ibrance Real World Insights (IRIS) study () collected real-world outcomes data for palbociclib-treated patients in several countries, including Canada. Methods: This retrospective chart review included women with HR+/HER2− ABC/MBC receiving P+L or P+F in Canada. Physicians reviewed medical records for up to 14 patients, abstracting demographic and clinical characteristics, treatment patterns, and clinical outcomes. Progression-free rates (PFRs) and survival rates (SRs) at 6, 12, 18, and 24 months were estimated via Kaplan–Meier analysis. Results: Thirty-three physicians examined medical records for 247 patients (P+L, n = 214; P+F, n = 33). Median follow-up was 8.8 months for P+L and 7.0 months for P+F. Most patients were initiated on palbociclib 125 mg/d (P+L, 90.2%; P+F, 84.8%). Doses were reduced in 16.6% of P+L and 14.3% of P+F patients initiating palbociclib at 125 mg/d. The PFR for P+L was 90.3% at 12 months and 78.2% at 18 months; corresponding SRs were 95.6% and 93.0%. For P+F, 6-month PFR was 91.0%; 12-month SR was 100.0%. Conclusions: Dose reduction rates were low and PFR and SR were high in this Canadian real-world assessment of P+L and P+F treatments, suggesting that palbociclib combinations are well tolerated and effective. NCT03159195相似文献
3.
4.
5.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
6.
7.
Guntur E Luis Chee-Khuen Yong Deepak A Singh S Sengupta David SK Choon 《Journal of orthopaedic surgery and research》2007,2(1):22-10
Background
Acromioclavicular injuries are common in sports medicine. Surgical intervention is generally advocated for chronic instability of Rockwood grade III and more severe injuries. Various methods of coracoclavicular ligament reconstruction and augmentation have been described. The objective of this study is to compare the biomechanical properties of a novel palmaris-longus tendon reconstruction with those of the native AC+CC ligaments, the modified Weaver-Dunn reconstruction, the ACJ capsuloligamentous complex repair, screw and clavicle hook plate augmentation. 相似文献8.
9.
10.
The magnetic resonance (MR) images of six patients with thrombosis of a dural sinus were reviewed. The diagnosis had been verified by computed tomographic scans in three patients and arteriograms in two; in the sixth patient, only MR imaging was used to confirm the clinical syndrome. In all patients, high-intensity signal was seen from the thrombus within the affected dural sinus on all echoes. This persistent signal intensity allowed intravascular clot to be distinguished from normal causes of increased signal such as flow-related enhancement (entry phenomenon) and even-echo rephasing. MR imaging demonstrated the cause of the thrombosis in three patients: two were secondary to adjacent tumors, and one was secondary to unsuspected mastoiditis. Complications such as infarction were also demonstrated. Using MR imaging, one can easily and safely diagnose thrombosis of a dural sinus. MR should be the imaging method of choice in patients suspected of having thrombosis of a dural sinus. 相似文献